Your browser doesn't support javascript.
loading
Case Report: Recurrent retinal vein occlusion as the first clinical manifestation of systemic lupus erythematosus in a male patient.
Ben Brahim, Marwa; Arfa, Sondes; Boubaker, Fadia; Chelly, Jihen; Ammari, Wafa; Hammami, Sonia; Arbi, Fatma; Berriche, Olfa.
Afiliación
  • Ben Brahim M; Department of Internal Medicine and Endocrinology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
  • Arfa S; Department of Internal Medicine and Endocrinology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
  • Boubaker F; Department of Internal Medicine and Endocrinology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
  • Chelly J; Department of Internal Medicine and Endocrinology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
  • Ammari W; Department of Ophthalmology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
  • Hammami S; Department of Internal Medicine and Endocrinology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, 5000, Tunisia.
  • Arbi F; Biochemistry Laboratory,LR12ES05 LR-NAFS Nutrition-Functional Food and Vascular Health, Faculty of Medicine, University of Monastir, Monastir, 5000, Tunisia.
  • Berriche O; Department of Internal Medicine and Endocrinology, Taher Sfar University Hospital, University of Monastir, Mahdia, 5100, Tunisia.
F1000Res ; 10: 761, 2021.
Article en En | MEDLINE | ID: mdl-35814626
ABSTRACT
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by widespread clinical manifestations and immunological disorders. A myriad of ocular manifestations can be seen in patients with SLE. The most vision-threatening complication is vaso-occlusive retinopathy including retinal vein occlusion (RVO). RVO associated with SLE is well described in the literature and its association with antiphospholipid antibodies is recognized. However, RVO as the initial manifestation of SLE is scarcely reported. Herein, we report the first case of recurrent RVO as the revealing manifestation of SLE in a 40-year-old male patient. He had two consecutive episodes of decreased vision. Ophthalmologic examination disclosed a branch retinal vein occlusion the first time and a central retinal vein occlusion the second time. The diagnosis of SLE was established based on clinical and immunological criteria. He was prescribed antiplatelet therapy, hydroxychloroquine at 5.5 mg/kg/day, and intravitreal anti-vascular endothelial growth factor (VEGF) antibodies regimen. He slowly improved under treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adult / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adult / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article